ClinConnect ClinConnect Logo
Search / Trial NCT06152198

Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture

Launched by UPPSALA UNIVERSITY · Nov 21, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hip Fracture Femoral Neck Fracture Treatment Hip Arthroplasty Internal Fixation

ClinConnect Summary

This clinical trial is exploring the best surgical treatment for older adults with a specific type of hip fracture called an undisplaced femoral neck fracture. The study compares two common surgical options: internal fixation (using screws to hold the bone together) and hip arthroplasty (replacing the damaged joint with an artificial one). Researchers want to see how these procedures affect physical function and pain levels for patients at 4 and 12 months after surgery.

To be eligible for this study, patients must be older adults who have recently suffered an undisplaced femoral neck fracture and are able to give informed consent. They should be treated at a participating hospital and be suitable for either type of surgery. If chosen to participate, individuals will receive follow-up calls or letters to answer questions about their recovery and daily activities. This study will help doctors understand which treatment may offer better outcomes for older patients facing this type of hip fracture.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Undisplaced (Garden I-II) femoral neck fracture (within 72h)
  • Treated at participating unit
  • Informed consent
  • Amenable for both treatment options
  • Included in the Hipsther trial
  • Exclusion Criteria:
  • No informed consent
  • Pathological or stress fracture
  • Peri-implant fracture
  • Previous inclusion of a contralateral Garden 1 or 2 femoral neck fracture

About Uppsala University

Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.

Locations

Uppsala, , Sweden

Patients applied

0 patients applied

Trial Officials

Olof Wolf, MD, PhD

Principal Investigator

Uppsala University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported